Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.

The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications.

Open access

Abstract

Developments in high-throughput microbial genomic sequencing and other systems biology techniques have given novel insight into the potential contribution of the gut microbiota to health and disease. As a result, an increasing number of diseases have been characterised by distinctive changes in the composition and functionality of the gut microbiota; however, whether such changes are cause, consequence, or incidental to the disease in question remains largely uncertain. Restoration of the gut microbiota to a premorbid state is a key novel therapeutic approach of interest, and faecal microbiota transplantation-the transfer of prescreened stool from healthy donors into the gastrointestinal tract of patients-is gaining increasing importance in both the clinical and research settings. At present, faecal microbiota transplantation is only recommended in the treatment of recurrent Clostridioides difficile infection, although a large number of trials are ongoing worldwide exploring other potential therapeutic indications.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(19)31266-8

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 101 references

Research works printed but not linked: 9

  1. Cammarota, 2017, European Consensus Conference on faecal microbiota transplantation in clinical practice, Gut, 66, 569, 10.1136/gutjnl-2016-313017 · DOI · Paper page
  2. Davidovics, 2019, JPGN, 68, 130
  3. Mullish, 2018, The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines, Gut, 67, 1920, 10.1136/gutjnl-2018-316818 · DOI · Paper page
  4. 2017, Colon, The Am J Gastroenterol, 112, S45
  5. Rossen, 2015, Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis, Gastroenterology, 149, 110, 10.1053/j.gastro.2015.03.045 · DOI · Paper page
  6. Paramsothy, 2017, Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial, Lancet, 389, 1218, 10.1016/S0140-6736(17)30182-4 · DOI · Paper page
  7. Costello, 2019, Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial, JAMA, 321, 156, 10.1001/jama.2018.20046 · DOI · Paper page
  8. Moayyedi, 2015, Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial, Gastroenterology, 149, 102, 10.1053/j.gastro.2015.04.001 · DOI · Paper page
  9. McDonald, 2018, Inhibiting growth of Clostridioides difficile by restoring valerate, produced by the intestinal microbiota, Gastroenterology, 155, 1495, 10.1053/j.gastro.2018.07.014 · DOI · Paper page

Cited by

See all 358

Metadata

Authors
Allegretti, J. R., Mullish, B. H., Kelly, C., & Fischer, M.
Affiliations
  • Brigham and Women's Hospital (US)
  • Imperial College London (GB)
  • Brown University (US)
  • Indiana University Indianapolis (US)
Corresponding author
Allegretti, Jessica R
Venue
The Lancet
Publisher
Elsevier BV
Published
2019-08
Volume
394
Issue
10196
Pages
420-431
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2965461923
Cited by
358
References
101
Citations by year
2026: 38 · 2025: 42 · 2024: 52 · 2023: 40 · 2022: 48 · 2021: 57 · 2020: 72 · 2019: 9
FWCI
4.12
Type
journal article
Language
en
Open access
Licence
  • cc-by-nc-nd
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • Spiral (Imperial College London) (submittedVersion, cc-by-nc-nd)
Funders
Medical Research Council Clinical Research (MR/R000875/1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
fecal microbiota transplantation, gut microbiota, Clostridium difficile infection, microbiota-based therapy, donor screening, treatment indications, microbiota and disease
MeSH terms
Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Clostridium Infections, Humans, Randomized Controlled Trials as Topic, Treatment Outcome, Practice Guidelines as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications. https://app.cochat.ai/papers/10.1016/s0140-6736(19)31266-8
The paper
Allegretti, J. R., Mullish, B. H., Kelly, C., & Fischer, M. (2019). The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications. The Lancet. https://doi.org/10.1016/s0140-6736(19)31266-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.